Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Mol Cancer Ther. 2013 Dec 19;13(2):433–443. doi: 10.1158/1535-7163.MCT-13-0803

Figure 3. Comparison of the sensitivity patterns in the three PARP inhibitors across the NCI60 cell lines.

Figure 3

The IC50 (drug concentration that reduces cell survival down to 50%) obtained from the NCI60 databases (35, 41) (http://discover.nci.nih.gov/cellminer) is plotted for each cell line. Cell lines are colored according to tissue of origin (41). NA: data not available.